Mergers and acquisitions – Page 17

Business
GSK divests Lucozade and Ribena brands

2013-09-10T00:00:00Z

£1.35 billion deal allows GSK to focus on pharma business
Business
Otsuka to buy Astex for $886 million

2013-09-06T00:00:00Z

Japanese firm intends to leave Astex’s fragment-based R&D efforts intact
Business
Amgen snaps up Onyx in huge biotech deal

2013-09-04T00:00:00Z

$10.4 billion acquisition will expand firm’s oncology portfolio
Business
Endo Health to buy Boca Pharmacal for $225m

2013-09-02T00:00:00Z

Endo agrees to buy generics firm Boca as two major patents expire
Business
J&J buys Aragon’s prostate cancer arm

2013-08-22T00:00:00Z

Hormone cancer specialist spins out other programmes before sale
Business
AkzoNobel sells building adhesives unit for €260m

2013-08-12T00:00:00Z

Sika will take on two manufacturing sites and 550 employees
Business
Pfizer reshuffle hints at future split decision

2013-07-31T00:00:00Z

Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
Business
Perrigo bags Elan and its bargain Irish tax rates

2013-07-31T00:00:00Z

$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
Business
Thousands face job cuts after Valeant's Bausch buyout

2013-07-30T00:00:00Z

Valeant plans to shed 10-15% of its workforce to save $800 million
Business
Aspen in $1 billion deal with Merck & Co

2013-07-01T00:00:00Z

South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
Business
AstraZeneca stocks pipeline with acquisitions

2013-06-10T00:00:00Z

Spending spree continues with two more deals
Business
Bayer buys Conceptus for $1.1bn

2013-04-29T00:00:00Z

Deal gives German pharma giant access to surgery-free permanent birth control procedure
Business
Thermo Fisher to buy Life Technologies in $15.8bn deal

2013-04-19T00:00:00Z

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
Business
Dispute over Arkema finances

2013-03-13T00:00:00Z

French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine